Chronic complications after travelers' diarrhea

Journal of Travel Medicine

Volumn 20, Issue 5, 2013, Pages 273-274

  Dupont, Herbert L ^a,b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DIARRHEA; ASYMPTOMATIC INFECTION; CAMPYLOBACTER; CAMPYLOBACTER JEJUNI; EDITORIAL; ENTERITIS; ENTEROTOXIGENIC ESCHERICHIA COLI; GASTROENTERITIS; GUILLAIN BARRE SYNDROME; HUMAN; INTESTINE INFECTION; IRRITABLE COLON; PATHOGENESIS; REACTIVE ARTHRITIS; SUSCEPTIBLE POPULATION; TRAVELLER DIARRHEA;

ARTHRITIS, REACTIVE; DIARRHEA; GUILLAIN-BARRE SYNDROME; HUMANS; IRRITABLE BOWEL SYNDROME; TRAVEL;

EID: 84883348391     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/jtm.12045     Document Type: Editorial

References (20)

1. Steffen R, Tornieporth N, Clemens SA, et al. Epidemiology of travelers' diarrhea: details of a global survey. J Travel Med 2004; 11: 231-237.
2. Connor BA, Riddle MS,. Post-infectious sequelae of travelers' diarrhea. J Travel Med 2013; 20: 303-312.
3. Endtz HP, Ang CW, van Den Braak N, et al. Molecular characterization of Campylobacter jejuni from patients with Guillain-Barre and Miller Fisher syndromes. J Clin Microbiol 2000; 38: 2297-2301.
4. Toivanen P, Toivanen A,. Two forms of reactive arthritis? Ann Rheum Dis 1999; 58: 737-741.
5. Dunlop SP, Jenkins D, Spiller RC,. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003; 98: 1578-1583.
6. Spiller RC,. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol 2004; 18: 641-661.
7. Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL,. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am J Gastroenterol 2004; 99: 1774-1778.
8. Stermer E, Lubezky A, Potasman I, Paster E, Lavy A,. Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis 2006; 43: 898-901.
9. DuPont HL, Galler G, Garcia-Torres F, et al. Travel and travelers' diarrhea in patients with irritable bowel syndrome. Am J Trop Med Hyg 2010; 82: 301-305.
10. Tribble DR, Sanders JW, Pang LW, et al. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. Clin Infect Dis 2007; 44: 338-346.
11. Vlieghe ER, Jacobs JA, Van Esbroeck M, Koole O, Van Gompel A,. Trends of norfloxacin and erythromycin resistance of Campylobacter jejuni/Campylobacter coli isolates recovered from international travelers, 1994 to 2006. J Travel Med 2008; 15: 419-425.
12. Caporale CM, Papola F, Fioroni MA, et al. Susceptibility to Guillain-Barre syndrome is associated to polymorphisms of CD1 genes. J Neuroimmunol 2006; 177: 112-118.
13. Leirisalo M, Skylv G, Kousa M, et al. Follow-up study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 1982; 25: 249-259.
14. Villani AC, Lemire M, Thabane M, et al. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 2010; 138: 1502-1513.
15. Peltola H, Siitonen A, Kyronseppa H, et al. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet 1991; 338: 1285-1289.
16. DuPont HL, Ericsson CD, Farthing MJG, et al. Expert review of the evidence base for prevention of travelers' diarrhea. J Travel Med 2009; 16: 149-160.
17. Pickering LK, DuPont HL, Evans DG, Evans DJ Jr, Olarte J,. Isolation of enteric pathogens from asymptomatic students from the United States and Latin America. J Infect Dis 1977; 135: 1003-1005.
18. Rees JH, Soudain SE, Gregson NA, Hughes RA,. Campylobacter jejuni infection and Guillain-Barre syndrome. N Engl J Med 1995; 333: 1374-1379.
19. Gautret P, Schlagenhauf P, Gaudart J, et al. Multicenter EuroTravNet/GeoSentinel study of travel-related infectious diseases in Europe. Emerg Infect Dis 2009; 15: 1783-1790.
20. Swaminathan A, Torresi J, Schlagenhauf P, et al. A global study of pathogens and host risk factors associated with infectious gastrointestinal disease in returned international travellers. J Infect 2009; 59: 19-27.